
Glecaprevirâpibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studiesâ a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2)
Wei, Lai, Wang, Guiqiang, Alami, Negar N, Xie, Wen, Heo, Jeong, Xie, Qing, Zhang, Mingxiang, Kim, Yoon Jun, Lim, Seng Gee, Fredrick, Linda M, Lu, Wenjing, Liu, Wei, Kalluri, Hari V, Krishnan, Preethi,Journal:
The Lancet Gastroenterology & Hepatology
DOI:
10.1016/S2468-1253(20)30086-8
Date:
July, 2020
Fichier:
PDF, 505 KB
2020